Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
This randomized open-label study will be comprised of 2 cohorts: one control group and one
 treatment group. The trial will be conducted as an open label randomized trial to evaluate
 the efficacy of tamsulosin in the prevention of post-operative urinary retention. The study
 will include pre- and post-surgical evaluations of patients including symptoms of urinary
 retention and any adverse effects contributable to the study medication.
Inclusion Criteria:

 -  Any male age 40 or older

 -  Scheduled to undergo one of the planned surgeries (thoracic, general, or urologic)

 -  Ability to give informed consent

 Exclusion Criteria:

 -  Current use of alpha blocker

 -  Current use of a strong CYP 3A4 inhibitors

 -  Any allergy to tamsulosin, alpha-blocker medication class, or anaphylaxis allergy to
 sulfate containing medications

 -  Patients with any upcoming surgery for cataracts

 -  Currently enrolled in a clinical trial

 -  Inability to give informed consent